FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections

FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections

Source: 
MSN/Reuters
snippet: 

AbbVie said that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections on Friday.